adverse side effects of glp 1 May 4, 2025: New study suggests more events associated with compounded GLP-1s than standard formulations – Partnership for Safe Medicines glp-1 and gastroparesis class action

and cellular energetics.152 At the cellular level, it is thought to decrease the enzymatic activity of both the Krebs cycle and the mitochondrial respiratory chain.153 Iron deficiency has been related to decreased exercise capacity (measured with both peak VO 2 max and 6-minute walking distance) and quality of life in HFpEF patients.154 Moreover, a recent study has shown that iron deficiency in HFpEF is significantly associated with a 3.5-fold increase in all-cause mortality, but not with HF hospitalisations ( Table 3 ).155 The on-going FAIR-HFpEF study is evaluating the effects of intravenous iron therapy on exercise capacity, mortality and HF-related hospitalisation rates, as has been previously reported in HFrEF patients.156 Novel Biomarkers Circulating microRNAs Circulating microRNAs (miRNAs) offer attractive potential as epigenetic disease biomarkers by virtue of their biological stability and ready accessibility in liquid biopsies

N Engl J Med 1998

Copper peptides can justify their cost when the formula is simple, the texture encourages daily use, and the user is willing to stay consistent

Rationale for Exploring High-Potency GLP-1 Therapies Several GLP-1 receptor agonists are approved for pediatric T2D, supported by guidelines as adjunctive treatments to metformin